These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Idiosyncratic drug-induced liver injury: A short review. Yamashita YI; Imai K; Mima K; Nakagawa S; Hashimoto D; Chikamoto A; Baba H Hepatol Commun; 2017 Aug; 1(6):494-500. PubMed ID: 29404475 [TBL] [Abstract][Full Text] [Related]
4. Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury. Benesic A; Leitl A; Gerbes AL Gut; 2016 Sep; 65(9):1555-63. PubMed ID: 26045135 [TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Test to Identify Drugs That Cause Idiosyncratic Drug-Induced Liver Injury. Benesic A; Rotter I; Dragoi D; Weber S; Leitl A; Buchholtz ML; Gerbes AL Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1488-1494.e5. PubMed ID: 29723689 [TBL] [Abstract][Full Text] [Related]
6. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report. Xie W; Wang Q; Gao Y; Pan CQ BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a human in vitro hepatocyte-NPC co-culture model for the prediction of idiosyncratic drug-induced liver injury: A pilot study. Granitzny A; Knebel J; Müller M; Braun A; Steinberg P; Dasenbrock C; Hansen T Toxicol Rep; 2017; 4():89-103. PubMed ID: 28959630 [TBL] [Abstract][Full Text] [Related]
10. Mouse precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury. Hadi M; Chen Y; Starokozhko V; Merema MT; Groothuis GM Chem Res Toxicol; 2012 Sep; 25(9):1938-47. PubMed ID: 22870868 [TBL] [Abstract][Full Text] [Related]
11. Editor's Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI. Mak A; Kato R; Weston K; Hayes A; Uetrecht J Toxicol Sci; 2018 Feb; 161(2):412-420. PubMed ID: 29087505 [TBL] [Abstract][Full Text] [Related]
12. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury. Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188 [TBL] [Abstract][Full Text] [Related]
13. Human precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury. Hadi M; Westra IM; Starokozhko V; Dragovic S; Merema MT; Groothuis GM Chem Res Toxicol; 2013 May; 26(5):710-20. PubMed ID: 23565644 [TBL] [Abstract][Full Text] [Related]
14. A rare coexistence: drug induced hepatitis and meningitis in association with Ibuprofen. Nayudu SK; Kavuturu S; Niazi M; Daniel M; Dev A; Kumbum K J Clin Med Res; 2013 Jun; 5(3):243-6. PubMed ID: 23671551 [TBL] [Abstract][Full Text] [Related]
15. Use of an animal model to test whether non-alcoholic fatty liver disease increases the risk of idiosyncratic drug-induced liver injury. Mak A; Cho T; Uetrecht J J Immunotoxicol; 2018 Dec; 15(1):90-95. PubMed ID: 29733743 [TBL] [Abstract][Full Text] [Related]
18. Do In Vitro Assays Predict Drug Candidate Idiosyncratic Drug-Induced Liver Injury Risk? Kenna JG; Uetrecht J Drug Metab Dispos; 2018 Nov; 46(11):1658-1669. PubMed ID: 30021844 [TBL] [Abstract][Full Text] [Related]
19. The role of quantitative systems pharmacology modeling in the prediction and explanation of idiosyncratic drug-induced liver injury. Woodhead JL; Watkins PB; Howell BA; Siler SQ; Shoda LKM Drug Metab Pharmacokinet; 2017 Feb; 32(1):40-45. PubMed ID: 28129975 [TBL] [Abstract][Full Text] [Related]
20. [Discussion on influence factors, mechanism and traditional Chinese medicine pathogenesis of idiosyncratic drug-induced liver injury]. Wang G; Liu Y; Hou XF; Song J; Qiu HH; Zhong QX; Jia XB; Wang FJ; Jiang N; Ke ZC; Feng L Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(16):3036-3043. PubMed ID: 29171218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]